After three weeks, all control mice showed bioluminescence rapid tumor growth, while the clone 142-derived anti-CD30 CAR-T cells efficiently inhibited tumor engraftment, sustaining a complete remission from the first tumor injection due to prolonged CAR-mediated immune memory (Figure 7E). The gene discussed is TNFRSF8; the disease is neoplasm.